SU1410866A3 - Способ получени стеарата ацетилэритромицина - Google Patents

Способ получени стеарата ацетилэритромицина Download PDF

Info

Publication number
SU1410866A3
SU1410866A3 SU853836820A SU3836820A SU1410866A3 SU 1410866 A3 SU1410866 A3 SU 1410866A3 SU 853836820 A SU853836820 A SU 853836820A SU 3836820 A SU3836820 A SU 3836820A SU 1410866 A3 SU1410866 A3 SU 1410866A3
Authority
SU
USSR - Soviet Union
Prior art keywords
erythromycin
stearate
trial
acetyl
acetylerythromycin
Prior art date
Application number
SU853836820A
Other languages
English (en)
Russian (ru)
Inventor
Лауриантеро Марвола Мартти
Вейкко Марттила Эско
Антеро Уотила Яакко
Килликки Пиппури Айно
Юхани Кайрисало Пекка
Юхани Хонканен Эркки
Original Assignee
Орион-Ихтюмя Ой (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орион-Ихтюмя Ой (Фирма) filed Critical Орион-Ихтюмя Ой (Фирма)
Application granted granted Critical
Publication of SU1410866A3 publication Critical patent/SU1410866A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
SU853836820A 1984-01-06 1985-01-04 Способ получени стеарата ацетилэритромицина SU1410866A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
SU1410866A3 true SU1410866A3 (ru) 1988-07-15

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
SU853836820A SU1410866A3 (ru) 1984-01-06 1985-01-04 Способ получени стеарата ацетилэритромицина

Country Status (38)

Country Link
US (1) US4599326A (2)
JP (1) JPS60158197A (2)
KR (1) KR900006237B1 (2)
AT (1) AT386414B (2)
AU (1) AU565688B2 (2)
BE (1) BE901411A (2)
BG (1) BG43189A3 (2)
CA (1) CA1224461A (2)
CH (1) CH666275A5 (2)
CS (1) CS247191B2 (2)
CY (1) CY1462A (2)
DE (1) DE3500179A1 (2)
DK (1) DK149776C (2)
ES (1) ES8605818A1 (2)
FI (1) FI77249C (2)
FR (1) FR2557878B1 (2)
GB (1) GB2152502B (2)
HK (1) HK11590A (2)
HU (1) HU196221B (2)
IE (1) IE57967B1 (2)
IL (1) IL73885A (2)
IS (1) IS2968A7 (2)
IT (1) IT1184304B (2)
KE (1) KE3841A (2)
LU (1) LU85721A1 (2)
MA (1) MA20316A1 (2)
MX (1) MX156277A (2)
NL (1) NL8403979A (2)
NO (1) NO160263C (2)
NZ (1) NZ210606A (2)
PH (1) PH22471A (2)
PL (1) PL144349B1 (2)
PT (1) PT79777B (2)
RO (1) RO91262B (2)
SE (1) SE461854B (2)
SU (1) SU1410866A3 (2)
YU (1) YU44485B (2)
ZA (1) ZA8410143B (2)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2005041925A2 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption
EP1765292B1 (en) 2004-06-12 2017-10-04 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
EP1789075A4 (en) 2004-08-25 2009-07-01 Uab Research Foundation ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP2158898A1 (en) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilizing alkylglycoside compositions and method thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
AU2012255116B2 (en) 2011-05-18 2017-05-25 Mederis Diabetes, Llc Improved peptide pharmaceuticals
EP3444281B1 (en) 2012-11-20 2021-11-03 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
JP6525456B2 (ja) 2012-11-20 2019-06-05 メデリス ダイアビーティーズ，エルエルシー インスリン抵抗性のための改善されたペプチド製剤
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
PT3155017T (pt) 2014-05-28 2024-05-14 Mederis Diabetes Llc Farmacêuticos peptídicos melhorados para resistência à insulina
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
US11160821B2 (en) * 2017-05-19 2021-11-02 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
CA3083487A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
FI3678649T3 (fi) 2018-02-06 2023-01-31 Nenänsisäisiä epinefriiniformulaatioita ja sairauden hoitomenetelmiä
PE20220499A1 (es) * 2018-12-17 2022-04-07 Lunella Biotech Inc Terapias de combinacion triple para anti-envejecimiento
KR20210104829A (ko) * 2018-12-17 2021-08-25 루넬라 바이오테크 인코포레이티드 미토콘드리아를 표적화하고 암 줄기 세포를 사멸시키는 삼중 조합 요법
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Патент GB V 834347, кл. 2 (3)А, опублик. 1960. *

Also Published As

Publication number Publication date
NO850007L (no) 1985-07-08
FI850023A0 (fi) 1985-01-03
YU44485B (en) 1990-08-31
CY1462A (en) 1989-07-21
PL144349B1 (en) 1988-05-31
DK5884D0 (da) 1984-01-06
IE850022L (en) 1985-07-06
MA20316A1 (fr) 1985-10-01
IL73885A0 (en) 1985-03-31
IE57967B1 (en) 1993-06-02
DE3500179A1 (de) 1985-07-18
NO160263C (no) 1989-03-29
PH22471A (en) 1988-09-12
IL73885A (en) 1988-10-31
GB2152502A (en) 1985-08-07
DK149776B (da) 1986-09-29
NO160263B (no) 1988-12-19
BE901411A (fr) 1985-04-16
RO91262B (ro) 1987-07-01
NL8403979A (nl) 1985-08-01
PT79777A (en) 1985-01-01
SE8406671D0 (sv) 1984-12-28
MX156277A (es) 1988-08-04
CA1224461A (en) 1987-07-21
SE461854B (sv) 1990-04-02
HUT37628A (en) 1986-01-23
AU565688B2 (en) 1987-09-24
LU85721A1 (fr) 1985-07-24
GB8432368D0 (en) 1985-02-06
ES8605818A1 (es) 1986-04-01
CH666275A5 (de) 1988-07-15
BG43189A3 (en) 1988-04-15
ATA985A (de) 1988-01-15
SE8406671L (sv) 1985-07-07
PT79777B (en) 1986-10-21
RO91262A (ro) 1987-06-30
DE3500179C2 (2) 1989-08-24
NZ210606A (en) 1987-08-31
JPH029040B2 (2) 1990-02-28
HK11590A (en) 1990-02-23
KE3841A (en) 1989-04-07
US4599326A (en) 1986-07-08
FR2557878B1 (fr) 1988-01-15
IT1184304B (it) 1987-10-28
FR2557878A1 (fr) 1985-07-12
FI77249B (fi) 1988-10-31
IT8519012A0 (it) 1985-01-04
KR900006237B1 (ko) 1990-08-27
YU2085A (en) 1987-12-31
ES539349A0 (es) 1986-04-01
IS2968A7 (is) 1985-04-03
KR850005452A (ko) 1985-08-26
PL251457A1 (en) 1985-11-05
CS247191B2 (en) 1986-12-18
JPS60158197A (ja) 1985-08-19
AU3705984A (en) 1985-07-11
GB2152502B (en) 1987-10-07
ZA8410143B (en) 1985-08-28
DK149776C (da) 1987-04-21
FI850023L (fi) 1985-07-07
FI77249C (fi) 1989-02-10
DK5884A (da) 1985-07-07
HU196221B (en) 1988-10-28
AT386414B (de) 1988-08-25

Similar Documents

Publication Publication Date Title
US4599326A (en) Acetyl erythromycin stearate, and compositions containing it
EP1421093B1 (en) Crystaline clindamycin free base
JPH03505448A (ja) 遅延放出性製剤
FR2464717A1 (fr) Compositions d'agents anti-microbiens a liberation maitrisee et leur utilisation
JPS63258841A (ja) チロシン誘導体及びその用途
US3873715A (en) Therapeutic agent for improving cardiovascular function
HU197770B (en) Process for producing the new 9-square brackets open (2'r, 3'r, 4's)-3',4'-bis(hydroxymethyl)-2'-oxetanyl square brackets closed-hypoxanthine and pharmaceutical compositions comprising same as active ingredient
CA1140857A (en) Spiroketalins and their applications
US3250679A (en) Penicillin derivative
GB1577545A (en) Treatment of swine dysenter
US3996356A (en) Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
US2756226A (en) Acid-stable penicillins
JPS604189B2 (ja) 抗菌剤およびその製法
US3000874A (en) Sulfate salt of erythromycin monoester
US4141971A (en) Derivatives of midecamycine
CN114984004B (zh) 硫酸舒欣啶在制备抗脓毒症药物中的应用
JPS5852291A (ja) ペニシリン系抗生物質誘導体とその医薬剤
US3962455A (en) Antibiotic ascofuranone and process for the production thereof
JPS5950318B2 (ja) 新規抗生物質ｓｙ−２物質
US3773958A (en) Methods of producing anti-arthritic activity using 3-substituted-thio-2,4-thiazolidinedione
JPH01180833A (ja) 血管新生剤
JPS59161386A (ja) セフアロスポリン誘導体及び該誘導体を含有する医薬
JPS60252420A (ja) 動物のウイルス性下痢症の予防治療剤
JPS6332794B2 (2)
JPS5849386A (ja) セフアロスポリン誘導体及び該誘導体を含有する医薬